biowaivers
Implementing New Guidelines to Optimise Bioequivalence and Bioavailability Studies
June 22 by Pharma IQ NewsTwo thirds of clinical studies worldwide are bioequivalence studies, so who can afford not to be up to date with the latest guidelines? Companies need to leverage these regulations to ensure effic...
Guidelines are Not Recipes: Biowaivers and Beyond
March 28 by Anders FuglsangAhead of the 2nd Annual Bioequivalence and Bioavailability Studies conference, Pharma IQ caught up with Anders Fuglsang from FuglsangPharma. Fuglsang is a former EU regulator (clinical asses...